Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Parnell

Showing results (161-170 of 180) with videos related to

Pageof 18
Sort By:
Aging Cell|December 6, 2014
Genetic variants modify the effect of age on APOE methylation in the Genetics of Lipid Lowering Drugs and Diet Network studyYiyi Ma, Caren E Smith, Chao-Qiang Lai, et al.
The American Journal of Clinical Nutrition|September 15, 2020
Carbohydrate and fat intake associated with risk of metabolic diseases through epigenetics of CPT1AChao-Qiang Lai, Laurence D Parnell, Caren E Smith, et al.
The American Journal of Clinical Nutrition|July 22, 2016
Interaction of an S100A9 gene variant with saturated fat and carbohydrates to modulate insulin resistance in 3 populations of different ancestriesRuth Blanco-Rojo, Javier Delgado-Lista, Yu-Chi Lee, et al.
Clinical Chemistry|April 28, 2020
Salivary AMY1 Copy Number Variation Modifies Age-Related Type 2 Diabetes RiskYuwei Liu, Caren E Smith, Laurence D Parnell, et al.
Metabolism: Clinical and Experimental|August 11, 2015
Genome-wide association study of triglyceride response to a high-fat meal among participants of the NHLBI Genetics of Lipid Lowering Drugs and Diet Network (GOLDN)Mary K Wojczynski, Laurence D Parnell, Toni I Pollin, et al.
Plos One|August 19, 2015
Diet- and Genetically-Induced Obesity Differentially Affect the Fecal Microbiome and Metabolome in Apc1638N MiceAnna C Pfalzer, Paula-Dene C Nesbeth, Laurence D Parnell, et al.
The Journal of Clinical Endocrinology and Metabolism|February 11, 2011
Interleukin 1B variant -1473G/C (rs1143623) influences triglyceride and interleukin 6 metabolismJavier Delgado-Lista, Antonio Garcia-Rios, Pablo Perez-Martinez, et al.
Molecular Aspects of Medicine|May 13, 2014
Dietary modulators of statin efficacy in cardiovascular disease and cognitionHuifen Wang, Jeffrey B Blumberg, C-Y Oliver Chen, et al.
The American Journal of Clinical Nutrition|December 6, 2008
Association between glucokinase regulatory protein (GCKR) and apolipoprotein A5 (APOA5) gene polymorphisms and triacylglycerol concentrations in fasting, postprandial, and fenofibrate-treated statesPablo Perez-Martinez, Dolores Corella, Jian Shen, et al.
BMJ Open Diabetes Research & Care|August 20, 2021
Associations of network-derived metabolite clusters with prevalent type 2 diabetes among adults of Puerto Rican descentDanielle E Haslam, Liming Liang, Dong D Wang, et al.
Pageof 18

Showing results (161-170 of 180) with videos related to

Sort By:
Pageof 18
Aging Cell|December 6, 2014
Genetic variants modify the effect of age on APOE methylation in the Genetics of Lipid Lowering Drugs and Diet Network studyYiyi Ma, Caren E Smith, Chao-Qiang Lai, et al.
The American Journal of Clinical Nutrition|September 15, 2020
Carbohydrate and fat intake associated with risk of metabolic diseases through epigenetics of CPT1AChao-Qiang Lai, Laurence D Parnell, Caren E Smith, et al.
The American Journal of Clinical Nutrition|July 22, 2016
Interaction of an S100A9 gene variant with saturated fat and carbohydrates to modulate insulin resistance in 3 populations of different ancestriesRuth Blanco-Rojo, Javier Delgado-Lista, Yu-Chi Lee, et al.
Clinical Chemistry|April 28, 2020
Salivary AMY1 Copy Number Variation Modifies Age-Related Type 2 Diabetes RiskYuwei Liu, Caren E Smith, Laurence D Parnell, et al.
Metabolism: Clinical and Experimental|August 11, 2015
Genome-wide association study of triglyceride response to a high-fat meal among participants of the NHLBI Genetics of Lipid Lowering Drugs and Diet Network (GOLDN)Mary K Wojczynski, Laurence D Parnell, Toni I Pollin, et al.
Plos One|August 19, 2015
Diet- and Genetically-Induced Obesity Differentially Affect the Fecal Microbiome and Metabolome in Apc1638N MiceAnna C Pfalzer, Paula-Dene C Nesbeth, Laurence D Parnell, et al.
The Journal of Clinical Endocrinology and Metabolism|February 11, 2011
Interleukin 1B variant -1473G/C (rs1143623) influences triglyceride and interleukin 6 metabolismJavier Delgado-Lista, Antonio Garcia-Rios, Pablo Perez-Martinez, et al.
Molecular Aspects of Medicine|May 13, 2014
Dietary modulators of statin efficacy in cardiovascular disease and cognitionHuifen Wang, Jeffrey B Blumberg, C-Y Oliver Chen, et al.
The American Journal of Clinical Nutrition|December 6, 2008
Association between glucokinase regulatory protein (GCKR) and apolipoprotein A5 (APOA5) gene polymorphisms and triacylglycerol concentrations in fasting, postprandial, and fenofibrate-treated statesPablo Perez-Martinez, Dolores Corella, Jian Shen, et al.
BMJ Open Diabetes Research & Care|August 20, 2021
Associations of network-derived metabolite clusters with prevalent type 2 diabetes among adults of Puerto Rican descentDanielle E Haslam, Liming Liang, Dong D Wang, et al.
Pageof 18